Gema González‐Pardo

564 total citations
9 papers, 454 citations indexed

About

Gema González‐Pardo is a scholar working on Infectious Diseases, Hepatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gema González‐Pardo has authored 9 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Hepatology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gema González‐Pardo's work include HIV/AIDS drug development and treatment (6 papers), Hepatitis C virus research (5 papers) and HIV Research and Treatment (2 papers). Gema González‐Pardo is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Hepatitis C virus research (5 papers) and HIV Research and Treatment (2 papers). Gema González‐Pardo collaborates with scholars based in Spain, China and France. Gema González‐Pardo's co-authors include Vincent Soriano, Sonia Rodríguez‐Nóvoa, Judit Morelló, Inmaculada Jiménez‐Nácher, Juan González‐Lahoz, Pablo Barreiro, Saye Khoo, Andrew Owen, David Back and Pablo Labarga and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and AIDS.

In The Last Decade

Gema González‐Pardo

9 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gema González‐Pardo Spain 7 348 169 128 112 97 9 454
Marc Antoine Valantin France 9 309 0.9× 217 1.3× 199 1.6× 162 1.4× 58 0.6× 17 579
Amelia S. Petry United States 7 367 1.1× 209 1.2× 119 0.9× 50 0.4× 78 0.8× 9 423
L. Tong United States 8 529 1.5× 261 1.5× 123 1.0× 142 1.3× 134 1.4× 10 648
Simona Landonio Italy 17 615 1.8× 335 2.0× 203 1.6× 256 2.3× 79 0.8× 32 776
Rosa Ruiz-Valderas Spain 12 342 1.0× 160 0.9× 189 1.5× 35 0.3× 52 0.5× 26 457
Clotilde Le Tiec France 8 330 0.9× 216 1.3× 78 0.6× 66 0.6× 74 0.8× 10 432
Andrew Luber United States 9 315 0.9× 167 1.0× 120 0.9× 39 0.3× 40 0.4× 22 395
Magda Opsomer Belgium 12 422 1.2× 293 1.7× 78 0.6× 123 1.1× 41 0.4× 29 517
Catherine Knupp United States 7 320 0.9× 232 1.4× 170 1.3× 54 0.5× 39 0.4× 9 471
Miwako Honda Japan 11 314 0.9× 113 0.7× 181 1.4× 145 1.3× 43 0.4× 20 456

Countries citing papers authored by Gema González‐Pardo

Since Specialization
Citations

This map shows the geographic impact of Gema González‐Pardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gema González‐Pardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gema González‐Pardo more than expected).

Fields of papers citing papers by Gema González‐Pardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gema González‐Pardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gema González‐Pardo. The network helps show where Gema González‐Pardo may publish in the future.

Co-authorship network of co-authors of Gema González‐Pardo

This figure shows the co-authorship network connecting the top 25 collaborators of Gema González‐Pardo. A scholar is included among the top collaborators of Gema González‐Pardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gema González‐Pardo. Gema González‐Pardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Morelló, Judit, Vincent Soriano, Pablo Barreiro, et al.. (2010). Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C. Antimicrobial Agents and Chemotherapy. 54(4). 1647–1649. 19 indexed citations
2.
Rodríguez‐Nóvoa, Sonia, Pablo Labarga, Vincent Soriano, et al.. (2009). Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study. Clinical Infectious Diseases. 48(11). e108–e116. 194 indexed citations
3.
Morelló, Judit, Carmen de Mendoza, Vincent Soriano, et al.. (2009). Use of Different Inhibitory Quotients To Predict Early Virological Response to Tipranavir in Antiretroviral-Experienced Human Immunodeficiency Virus-Infected Patients. Antimicrobial Agents and Chemotherapy. 53(10). 4153–4158. 5 indexed citations
4.
Rodríguez‐Nóvoa, Sonia, Judit Morelló, Pablo Barreiro, et al.. (2008). Switch from Ritonavir-Boosted to Unboosted Atazanavir Guided by Therapeutic Drug Monitoring. AIDS Research and Human Retroviruses. 24(6). 821–825. 31 indexed citations
5.
Morelló, Judit, Sonia Rodríguez‐Nóvoa, Carmen de Mendoza, et al.. (2008). Short Communication: Association between Tipranavir Plasma Levels and Virological Response in HIV-Infected Patients. AIDS Research and Human Retroviruses. 24(3). 389–391. 2 indexed citations
6.
Rodríguez‐Nóvoa, Sonia, Judit Morelló, Eugenia Vispo, et al.. (2008). Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin. AIDS. 22(18). 2535–2537. 33 indexed citations
7.
Rodríguez‐Nóvoa, Sonia, Pilar García‐Gascó, Francisco J. Blanco, et al.. (2007). Value of the HLA-B*5701 Allele to Predict Abacavir Hypersensitivity in Spaniards. AIDS Research and Human Retroviruses. 23(11). 1374–1376. 23 indexed citations
9.
Rodríguez‐Nóvoa, Sonia, Luz Martı́n-Carbonero, Pablo Barreiro, et al.. (2006). Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia. AIDS. 21(1). 41–46. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026